Resistant pleural effusion.
Conditions
Interventions
Intervention group:In this study, 20 patients received betadine in one step. 20 cc of 10% betadine is injected with 60 cc of normal saline and 5 cc of lidocaine and the catheter is removed and two wee
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: In this study, patients with refractory pleural effusion with adhesions and a history of VATS and thoracoscopy are eligible for the study.
Exclusion criteria
Exclusion criteria: In contrast, patients who have a mass for whom catheterization is not possible will be excluded from the study process
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pleural effusion, reduction of pleural effusion. Timepoint: monthly. Method of measurement: Ultrasound of the pleural space. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce dyspnea and cough. Timepoint: One week after pleural effusion injection. Method of measurement: In this study, a data collection form (Checklist) will be used to collect data. This form consists of 4 main parts. In the first part, the demographic characteristics of patients, including age and sex, as well as the type of pleural effusion disease, which is benign and malignant, are recorded. In the second part, the form of thyroid and kidney enzymes are recorded before and after the intervention. In the third part of the form, the length of the follow-up period and the final outcome of the treatment, which includes the success of the treatment and the failure of the treatment, are recorded. Side effects and patient complaints including chest pain, fever, shortness of breath, hypotension, vision loss, and air leakage are recorded at the end of the form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaranak Salajegheh
Kerman University of Medical Sciences
Outcome results
None listed